Evogene Ltd. (EVGN) insider trading.
In Q3 2026, insiders at Evogene Ltd. reported 3 non-derivative transactions on 7 Forms 3, 4 and 5: 3 open-market purchases worth $695K and 0 sales.
- Transactions
- 3
- Purchases (P)
- 3
- Sales (S)
- 0
- Net shares, P minus S
- 1,261,129
- Insiders
- 2
- Last filed
- 2026-08-26
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Recanati Leon | Director | 2 | 2 | 0 |
| Tarcic Gabi | Officer · Chief Development Officer | 1 | 1 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-11 | Recanati Leon | P (A) | 460,000 | $0.64 | 1,343,886 | Form 4 |
| 2026-08-04 | Recanati Leon | P (A) | 800,000 | $0.5 | 883,886 | Form 4 |
| 2026-06-04 | Tarcic Gabi | P (A) | 1,129 | $0.6 | 1,129 | Form 4 |
Transaction codes in this quarter
Get EVGN insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1574565&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · EVGN company page · Evogene Ltd. on SEC.gov
Questions
Are insiders buying or selling Evogene Ltd. (EVGN)?
In Q3 2026, insiders at Evogene Ltd. reported 3 non-derivative transactions on 7 Forms 3, 4 and 5: 3 open-market purchases worth $695K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Evogene Ltd. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/evgn.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.